首页   按字顺浏览 期刊浏览 卷期浏览 Primary Sclerosing Cholangitis in Arab Children: Report of Four Cases and Literature Re...
Primary Sclerosing Cholangitis in Arab Children: Report of Four Cases and Literature Review

 

作者: Kagalwalla,   A. Altraif*,   I. Shamsan,   L. Omojola†,   M. Khan*,   H. Kagalwalla‡,  

 

期刊: Journal of Pediatric Gastroenterology and Nutrition  (OVID Available online 1997)
卷期: Volume 24, issue 2  

页码: 146-152

 

ISSN:0277-2116

 

年代: 1997

 

出版商: OVID

 

关键词: Primary sclerosing cholangitis;Inflammatory bowel disease;ERCP;Ursodeoxycholic acid;Autoimmune hepatitis

 

数据来源: OVID

 

摘要:

Background:The prevalence of primary sclerosing cholangitis, a rare progressive liver disorder, is increasing with the advent of endoscopic retrograde cholangiography in the investigation of children with obscure liver disease. The etiology of primary sclerosing cholangitis is not known, clinical presentation is variable, treatment is only of limited success and long-term studies on prognosis in children are incomplete. Primary sclerosing cholangitis has not been described in Arab children.Methods:To describe detailed clinical, laboratory, histologic and radiological features in 4 children with primary sclerosing cholangitis identified over a 2-year period at a tertiary referral center in Riyadh Saudi Arabia.Results:Four children, all females, between the ages of 4 and 11 years with primary sclerosing cholangitis are identified. The diagnosis was suggested by the histology and confirmed by the characteristic cholangiographic findings. Clinical findings were itching in all 4 children, hepatomegaly in 3 and splenomegaly in 4 patients. Three of 4 patients had portal hypertension and 2 of these three variceal hemorrhage. Antinuclear and smooth muscle antibodies were negative in all four patients. None had clinical manifestations of chronic inflammatory bowel disease but microscopic colitis was documented in all 4 patients.Conclusions:Primary sclerosing cholangitis is present in Arab children with a prevalence rate of 5% in our study population.

 



返 回